Granules India Subsidiary Receives VAI Classification from US FDA Inspection

Granules India Limited announced that its wholly owned subsidiary, Granules Life Sciences Private Limited, has received a Voluntary Action Indicated (VAI) classification from the US FDA following a recent inspection of its manufacturing facility at Shamirpet, Telangana. The inspection, conducted between December 15 and 19, 2025, resulted in no regulatory action being recommended. This development strengthens Granules India’s finished dosage manufacturing capabilities and enables multi-site manufacturing for approved products.